Pore dilation occurs in TRPA1 but not in TRPM8 channels - PubMed (original) (raw)
Pore dilation occurs in TRPA1 but not in TRPM8 channels
Jun Chen et al. Mol Pain. 2009.
Abstract
Abundantly expressed in pain-sensing neurons, TRPV1, TRPA1 and TRPM8 are major cellular sensors of thermal, chemical and mechanical stimuli. The function of these ion channels has been attributed to their selective permeation of small cations (e.g., Ca2+, Na+ and K+), and the ion selectivity has been assumed to be an invariant fingerprint to a given channel. However, for TRPV1, the notion of invariant ion selectivity has been revised recently. When activated, TRPV1 undergoes time and agonist-dependent pore dilation, allowing permeation of large organic cations such as Yo-Pro and NMDG+. The pore dilation is of physiological importance, and has been exploited to specifically silence TRPV1-positive sensory neurons. It is unknown whether TRPA1 and TRPM8 undergo pore dilation. Here we show that TRPA1 activation by reactive or non-reactive agonists induces Yo-Pro uptake, which can be blocked by TRPA1 antagonists. In outside-out patch recordings using NMDG+ as the sole external cation and Na+ as the internal cation, TRPA1 activation results in dynamic changes in permeability to NMDG+. In contrast, TRPM8 activation does not produce either Yo-Pro uptake or significant change in ion selectivity. Hence, pore dilation occurs in TRPA1, but not in TRPM8 channels.
Figures
Figure 1
The activation of TRPA1, but not TRPM8, induced Yo-Pro uptake. A, in HEK-293F cells expressing rat TRPA1, AITC elevated intracellular Ca2+, as represented by increases of fluorescence signals (RFU) in the FLIPR based Ca2+ assay. B, in cells expressing TRPA1, AITC evoked robust Yo-Pro uptake in a concentration-dependent manner from the FLIPR based Yo-Pro uptake assays. C, in cells expressing human TRPM8, menthol activated TRPM8 and elevated intracellular Ca2+. D, in cells expressing TRPM8, menthol failed to induce Yo-Pro uptake. Compounds are in μM and additions are indicated by arrows.
Figure 2
Yo-Pro uptake was evoked by various TRPA1 agonists and blocked by TRPA1 antagonists. Concentration-effect relationships for agonist responses in the Ca2+ assay (A) and Yo-Pro uptake (B). Reactive agonists: AITC, CA and 4-HNE. Non-reactive agonists: FTS and URB597. Data are represented as percentage of maximal AITC responses. C, representative traces of Yo-Pro uptake in response to a first addition of AP18 (0 to 100 μM) and a second addition of AITC (30 μM). AP18 inhibited AITC evoked Yo-Pro uptake in a concentration-dependent manner. D, concentration-effect relationship of Yo-Pro uptake inhibition by AP18, HC-030031 and RR. (n = 4 – 8).
Figure 3
Ionic currents of TRPA1, but not TRPM8, exhibited shifts in reversal potential. Outside-out patches were formed from HeLa cells expressing rat TRPA1 or human TRPM8 plus GFP. NMDG+ was the sole external cation and Na+ was the major internal cation. Membrane potential was held at -80 mV, and a voltage ramp from -140 to 0 mV (500 ms duration) was applied every 3 s immediately. A, current traces from a representative TRPA1-containing patch during 60 s application of AITC (100 μM). To illustrate shifts in Erev, only currents between -6 to 8 pA were plotted. Inset shows the AITC-evoked currents were almost completely blocked by 10 μM RR. B, currents from a representative TRPM8-containing patch during 60 s application of menthol (500 μM). Note the shifts in Erev for TRPA1, but no shift for TRPM8.
Figure 4
Time-dependent changes in ion permeability occurred in TRPA1 but not in TRPM8. A, Erev values were determined (from Fig. 3 experiments) and plotted as a function of time after application of AITC or menthol. B, permeability ratios (PNMDG/PNa) before and 60 s after agonist addition. Student's t-test was used with p < 0.05 as the criterion for significance (indicated by *). C, changes in Erev and relative currents at 0 mV (from representative recordings) were plotted as a function of time after application of AITC. Outward currents were measured at 0 mV and normalized against the current obtained after 60 s addition of AITC.
Similar articles
- Dynamic changes in the TRPA1 selectivity filter lead to progressive but reversible pore dilation.
Banke TG, Chaplan SR, Wickenden AD. Banke TG, et al. Am J Physiol Cell Physiol. 2010 Jun;298(6):C1457-68. doi: 10.1152/ajpcell.00489.2009. Epub 2010 Mar 24. Am J Physiol Cell Physiol. 2010. PMID: 20457836 - Activation of TRPA1 by membrane permeable local anesthetics.
Leffler A, Lattrell A, Kronewald S, Niedermirtl F, Nau C. Leffler A, et al. Mol Pain. 2011 Aug 23;7:62. doi: 10.1186/1744-8069-7-62. Mol Pain. 2011. PMID: 21861907 Free PMC article. - Activation of TRPA1 channels by the fatty acid amide hydrolase inhibitor 3'-carbamoylbiphenyl-3-yl cyclohexylcarbamate (URB597).
Niforatos W, Zhang XF, Lake MR, Walter KA, Neelands T, Holzman TF, Scott VE, Faltynek CR, Moreland RB, Chen J. Niforatos W, et al. Mol Pharmacol. 2007 May;71(5):1209-16. doi: 10.1124/mol.106.033621. Epub 2007 Feb 21. Mol Pharmacol. 2007. PMID: 17314320 - TRP channels: targets for the relief of pain.
Levine JD, Alessandri-Haber N. Levine JD, et al. Biochim Biophys Acta. 2007 Aug;1772(8):989-1003. doi: 10.1016/j.bbadis.2007.01.008. Epub 2007 Jan 23. Biochim Biophys Acta. 2007. PMID: 17321113 Review. - TRPA1.
García-Añoveros J, Nagata K. García-Añoveros J, et al. Handb Exp Pharmacol. 2007;(179):347-62. doi: 10.1007/978-3-540-34891-7_21. Handb Exp Pharmacol. 2007. PMID: 17217068 Review.
Cited by
- TRPA1 mediates mechanical sensitization in nociceptors during inflammation.
Lennertz RC, Kossyreva EA, Smith AK, Stucky CL. Lennertz RC, et al. PLoS One. 2012;7(8):e43597. doi: 10.1371/journal.pone.0043597. Epub 2012 Aug 23. PLoS One. 2012. PMID: 22927999 Free PMC article. - The Preclinical Pharmacological Study of a Novel Long-Acting Local Anesthetic, a Fixed-Dose Combination of QX-OH/Levobupivacaine, in Rats.
Zhang Y, Yin Q, Gong D, Kang Y, Yang J, Liu J, Zhang W. Zhang Y, et al. Front Pharmacol. 2019 Aug 15;10:895. doi: 10.3389/fphar.2019.00895. eCollection 2019. Front Pharmacol. 2019. PMID: 31474859 Free PMC article. - Properties of the TRPML3 channel pore and its stable expansion by the Varitint-Waddler-causing mutation.
Kim HJ, Yamaguchi S, Li Q, So I, Muallem S. Kim HJ, et al. J Biol Chem. 2010 May 28;285(22):16513-20. doi: 10.1074/jbc.M109.078204. Epub 2010 Apr 8. J Biol Chem. 2010. PMID: 20378547 Free PMC article. - Selective cold pain inhibition by targeted block of TRPM8-expressing neurons with quaternary lidocaine derivative QX-314.
Ongun S, Sarkisian A, McKemy DD. Ongun S, et al. Commun Biol. 2018 May 31;1:53. doi: 10.1038/s42003-018-0062-2. eCollection 2018. Commun Biol. 2018. PMID: 30271936 Free PMC article. - Agonist-induced changes in Ca(2+) permeation through the nociceptor cation channel TRPA1.
Karashima Y, Prenen J, Talavera K, Janssens A, Voets T, Nilius B. Karashima Y, et al. Biophys J. 2010 Mar 3;98(5):773-83. doi: 10.1016/j.bpj.2009.11.007. Biophys J. 2010. PMID: 20197030 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous